Volume 7.21 | Jun 12

Immune Regulation News 7.21 June 12, 2015
Immune Regulation News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Like Us on Facebook  IRN on Twitter
 
TOP STORY
Researchers Expose How ‘James Bond’ Cells Are Made
Researchers revealed how immune cell ‘spies’ are created, providing clues on how the immune system could be manipulated to better fight disease. [Press release from the Walter and Eliza Hall Institute discussing online prepublication in Nature Immunology] Press Release | Abstract
Going to ISSCR 2015? We’ll see you there!
 
PUBLICATIONS (Ranked by impact factor of the journal)
Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection
Scientists showed that during acute gastrointestinal infection, priming of monocytes for regulatory function preceded systemic inflammation and was initiated prior to bone marrow egress. Notably, natural killer (NK) cell-derived IFN-γ promoted a regulatory program in monocyte progenitors during development. [Immunity]
Abstract | Graphical Abstract | Press Release

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
Researchers investigated the therapeutic potential of Lipoxin A4 (LXA4) and a synthetic 15(R)-Benzo-LXA4-analog as interventions in a three-month high-fat diet-induced obesity model. LXA4 decreased obesity-induced adipose inflammation, attenuating TNF-α and CD11c+ M1-macrophages (MΦs), while restoring CD206+ M2-MΦs and increasing Annexin-A1. [Cell Metab] Abstract | Graphical Abstract | Press Release

Active Targeting of Chemotherapy to Disseminated Tumors Using Nanoparticle-Carrying T Cells
In a murine model of disseminated lymphoma, researchers expanded autologous polyclonal T cells ex vivo under conditions that retained homing receptors mirroring lymphoma cells, and functionalized these T cells to carry SN-38–loaded nanocapsules on their surfaces. Nanocapsule-functionalized T cells were resistant to SN-38 but mediated efficient killing of lymphoma cells in vitro. [Sci Transl Med] Abstract

CCL2-Induced Chemokine Cascade Promotes Breast Cancer Metastasis by Enhancing Retention of Metastasis-Associated Macrophages
Scientists demonstrated that, through activation of the CC-chemokine ligand 2 (CCL2) receptor CCR2, recruited metastasis-associated macrophages (MAMs) secreted another chemokine ligand CCL3. Genetic deletion of CCL3 or its receptor CCR1 in macrophages reduced the number of lung metastasis foci, as well as the number of MAMs accumulated in tumor-challenged lung in mice. [J Exp Med] Abstract | Press Release

Inflammation Negatively Regulates FOXP3 and Regulatory T-Cell Function via DBC1
The authors report that Deleted in breast cancer 1 (DBC1) is a key subunit of the forkhead box P3 (FOXP3) complex. Treg cells from Dcb1-deficient mice were more resistant to inflammation-mediated abrogation of Foxp3 expression and function and delayed the onset and severity of experimental autoimmune encephalomyelitis and colitis in mice. [Proc Natl Acad Sci USA] Abstract

Focusing and Sustaining the Antitumor CTL Effector Killer Response by Agonist Anti-CD137 mAb
The marked synergistic effects of adoptive T cell and agonist anti-CD137 monoclonal Ab (mAbs) therapies were studied, providing in vivo evidence for improved, more sustained and focused tumoricidal functions of antitumor cytotoxic T lymphocytes (CTLs) when under the influence of CD137-targeted pharmacological stimulation with immunostimulatory monoclonal antibodies. [Proc Natl Acad Sci USA] Abstract

Immunosuppressive Potential of Human Amnion Epithelial Cells in the Treatment of Experimental Autoimmune Encephalomyelitis
Scientists investigated the immunoregulatory effects of human amnion epithelial cells (hAECs) as a potential therapy in a multiple sclerosis-like disease, experimental autoimmune encephalomyelitis, in mice. In vitro, hAECs suppressed both specific and non-specific T cell proliferation, decreased pro-inflammatory cytokine production, and inhibited the activation of stimulated T cells. [J Neuroinflammation] Full Article

Relevance of Foxp3+ Regulatory T Cells for Early and Late Phases of Murine Sepsis
To specifically evaluate the role of Foxp3+ regulatory T cells (Tregs) in the early and late phases of sepsis, investigators induced sepsis by cecal ligation and puncture and subsequent Pseudomonas aeruginosa lung infection in a DEREG mouse model. They found an increase of Foxp3+ Tregs to all CD4+ T cells during murine sepsis. [Immunology] Abstract

Don’t forget to subscribe to Human Immunology News and Immunology of Infectious Disease News!

Automate your cell isolations and increase laboratory throughput with RoboSep™-S. Explore features!
 
REVIEWS
Antibody-Independent Functions of B Cells: A Focus on Cytokines
The authors summarize the various roles of cytokine-producing B cells in immunity and discuss the rational for targeting these cells in the clinic. [Nat Rev Immunol] Abstract

Visit our reviews page to see a complete list of reviews in the immune regulation research field.

Invitation to Attend SMi 2nd Annual Immunogenicity Conference 2015
 
SCIENCE NEWS
Prothena’s NEOD001 Protein Immunotherapy Clinical Data Highlighted in Oral Presentation
Prothena Corporation plc announced that Dr. Michaela Liedtke of Stanford University School of Medicine presented data from the ongoing Phase I/II trial of NEOD001 in patients with AL amyloidosis and persistent organ dysfunction in an oral presentation. [Press release from Prothena Corporation plc discussing research presented at the 20th Congress of the European Hematology Association (EHA), Vienna] Press Release

From our sponsor: Isolate human immune cells in as little as 8 minutes with EasySep™. Request a sample.
 
INDUSTRY NEWS
Johnson & Johnson Innovation Announces 17 Collaborations with Focus on Advancing Global Healthcare through Transformational Science and Technologies
Johnson & Johnson Innovation announced 17 new collaborations with research institutions and healthcare companies. The announcement includes the first alliance for the Disease Interception Accelerator, a research agreement with Washington University to identify the root cause of type 1 diabetes and enable the development of interventions that halt progression to disease. [Johnson & Johnson Innovation] Press Release

Discovery of Cellular Mechanism of Action of tACPA in Rheumatoid Arthritis
ModiQuest B.V. announced that it has discovered the cellular mechanism of action of its therapeutic anti-citrullinated protein lead antibodies (tACPA) for the treatment of rheumatoid arthritis and other diseases. [ModiQuest B.V.] Press Release

STEMCELL Technologies Named Company of the Year by BIOTECanada
STEMCELL Technologies Inc. will be presented with the Biotech Company of the Year award by BIOTECanada at this year’s BIO International Convention in Philadelphia. [BIOTECanada] Press Release
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 2015 Midwest Conference on Cell Therapy & Regenerative Medicine
September 18-19, 2015
Kansas City, United States

Visit our events page to see a complete list of events in the immune regulation community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Antibody Engineering/Immuno-Oncology (California Institute for Biomedical Research)

Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Scientific Marketing Specialist – Immunology (STEMCELL Technologies Inc.)

Associate Director/Director – Immunology (Valera)

PhD Position – Molecular Immunology (VIB – Ghent University)

Head Stem Cells Immunotherapies Service Lab (NHS Blood and Transplant)

Postdoctoral Fellow – Immune Reconstitution in Hematopoietic Stem Cell Transplantation (Stanford University)

Process Facilitator (Opexa Therapeutics)

Postdoctoral Fellow – Immune Tolerance (Stanford University)

Postdoctoral Fellow – Immunology (Boston Children’s Hospital)

Postdoctoral Fellow – Immunopathogenesis of Multiple Sclerosis (University of Iowa)

Assistant Professor – Immunology (Northwestern University)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immune Regulation News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immune Regulation News: Archives | Events | Contact Us